Clinical Trials
2 trialsNCT00267592 2016-05-19
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00062504 2011-05-23
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated